Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors
- PMID: 14968115
- DOI: 10.1038/sj.onc.1207442
Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors
Abstract
Human papillomavirus (HPV) 16 is involved in causing cervical cancer. The E6 and E7 proteins of HPV 16 immortalize human keratinocytes and this is due, at least in part, to inactivation of the tumor suppressor proteins p53 and pRB. These tumor suppressor proteins also regulate the expression of pro- and antiangiogenic factors by cells. For this reason, experiments were conducted to determine whether the expression of E6 and E7 in primary keratinocytes alters the phenotype of these cells such that they express diminished levels of antiangiogenic factors and/or increased levels of proangiogenic factors. To avoid variances in experimental observations, pools of human foreskin keratinocytes from multiple sources were infected with recombinant retrovirus expressing HPV 16 E6 and E7 or control retrovirus. Gene array analysis, RT-PCR, ELISAs and Western blotting showed that in cells expressing HPV 16 E6 and E7, expression levels of two potent angiogenesis inhibitors, thrombospondin-1 and maspin, were lower compared to controls. Additionally, major angiogenesis inducers, interleukin-8 and vascular endothelial growth factor (VEGF), were increased relative to controls. VEGF can be produced as multiple splice variants, all of which are required for the formation of patent blood vessels. The expression of HPV 16 E6 and E7 in keratinocytes augmented expression of VEGF 121, 145, 165 and 189. These observations show that HPV 16 E6 and E7 alter the phenotype of primary keratinocytes, diminishing expression of inhibitors and increasing expression of inducers of angiogenesis. This altered phenotype may permit keratinocytes infected by HPV 16 to play a role in the progression of cancer by permitting tumors to acquire a blood supply permissive of growth and spread.
Similar articles
-
Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.Cancer Res. 2000 Aug 1;60(15):4289-98. Cancer Res. 2000. PMID: 10945644
-
The pro-angiogenic factors stimulated by human papillomavirus type 16 E6 and E7 protein in C33A and human fibroblasts.Oncol Rep. 2009 Jan;21(1):25-31. Oncol Rep. 2009. PMID: 19082439
-
Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.Oncogene. 2000 Sep 21;19(40):4611-20. doi: 10.1038/sj.onc.1203817. Oncogene. 2000. PMID: 11030150
-
Therapeutic vaccines against HPV16-associated tumors. Minireview.Neoplasma. 2002;49(5):285-9. Neoplasma. 2002. PMID: 12458324 Review.
-
[Non-melanoma skin cancers and human papillomavirus].Ann Dermatol Venereol. 2003 Dec;130(12 Pt 1):1131-8. Ann Dermatol Venereol. 2003. PMID: 14724516 Review. French.
Cited by
-
Human papillomavirus E6 and E7: What remains?Tumour Virus Res. 2021 Jun;11:200213. doi: 10.1016/j.tvr.2021.200213. Epub 2021 Feb 8. Tumour Virus Res. 2021. PMID: 33716206 Free PMC article. Review.
-
Proteomic Alterations in Salivary Exosomes Derived from Human Papillomavirus-Driven Oropharyngeal Cancer.Mol Diagn Ther. 2021 Jul;25(4):505-515. doi: 10.1007/s40291-021-00538-2. Epub 2021 Jun 2. Mol Diagn Ther. 2021. PMID: 34080172
-
Human papillomavirus up-regulates MMP-2 and MMP-9 expression and activity by inducing interleukin-8 in lung adenocarcinomas.PLoS One. 2013;8(1):e54423. doi: 10.1371/journal.pone.0054423. Epub 2013 Jan 21. PLoS One. 2013. PMID: 23349885 Free PMC article.
-
Profiling pancreatic cancer-secreted proteome using 15N amino acids and serum-free media.Pancreas. 2010 Jan;39(1):e17-23. doi: 10.1097/MPA.0b013e3181bc44dd. Pancreas. 2010. PMID: 19904223 Free PMC article.
-
Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases.Cancer Res. 2011 Feb 1;71(3):1187-95. doi: 10.1158/0008-5472.CAN-10-2626. Epub 2010 Dec 8. Cancer Res. 2011. PMID: 21148070 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous